The recent efforts of psychiatrist Karen Williams have prompted the New South Wales Government to develop concussion protocols for family and domestic abuse survivors.

In this blog post, we discuss a meta-analysis conducted by Xiaotian Shen et al.

In this blog post, we discuss a study published in NeuroImage by Danielle June et al. examined the long-term effects of concussion on brain structure and activity.

We delve into the Forbes article which details budget-friendly mental health support options that may be helpful for concussion patients.

The Portland Sleep Study is calling for study participants for a Morning Routine study for veterans. The federal Center for Neuroscience and Regenerative Medicine is looking for study participants for research on a cognitive behavioral therapy app for insomnia and TBI. The clinical trials are recruiting veterans and military service members.

Bader et al. investigated the treatment potential of two drugs, liraglutide and twincretin, in post-concussion mice. Mice treated with liraglutide and twincretin had less-elevated microglial activity, suggesting the drugs may minimize neuroinflammation after mTBI. Further, “Both drugs ameliorated mTBI-induced cognitive impairments” and neurodegeneration.

A study published in JMIR Pediatrics and Parenting evaluated current tele-concussion practices. With the Covid-19 pandemic challenging the United States’ healthcare system, many clinics have transitioned to telehealth practices to protect patients by eliminating inessential visits.

A British neuropsychologist has adapted to quarantine by creating online Tai Chi classes for stroke survivors and brain injury patients.

The hands of scientists dropping marijuana oil for experimentation and research, ecological hemp plant herbal pharmaceutical cbd oil from a jar.

This article discusses concussion causes, symptoms, and risks for dancers.

This is a case study of home-use, self-treatment photobiomodulation (light therapy) for a professional hockey player with persistent post-concussion (PCS) symptoms.

This month, Oxeia Biopharmaceuticals will be launching their Phase 2 trials of their drug treatment for concussion, OXE-103, a synthetic form of the hormone ghrelin. Co-Founder Dr. Vishal Bansal details why OXE-103 has an advantage over other types of treatments being researched.

This month, Oxeia Biopharmaceuticals will be launching their Phase 2 trials of their drug treatment for concussion, OXE-103, a synthetic form of the hormone ghrelin. CEO MIchael Wyand discusses the challenges of being the first potential drug for concussion to go through the FDA review process, and more.

A study found that there was no documentation of an mTBI (concussion) evaluation for 50% of the “patients at high risk for mild traumatic brain injury.” Furthermore, of the 36 patients who received an mTBI diagnosis, only 15 received mTBI specific discharge information.

A study found symptoms were worse, and recovery was slower in adolescents (aged 11-19 years) who continued to play after suffering a concussion.

Sarah Gallagher, PT, DPT, NCS is the owner of South Valley Physical Therapy and is a member of the Vestibular Disorders Association, American Physical Therapy Association and Academy of Neurology. In her interview, she explains her center's operations and its role in telehealth.

Dr. Michael Hoffer, an otolaryngologist (ear nose and throat doctor), is working alongside a team of researchers at the University of Miami on a five-year study that will evaluate the efficacy of a new cannabinoid-based pill as a concussion treatment.

Dr. Monica Vavilala is is an anesthesiologist and director of Harborview’s Injury Prevention and Research Center, based in Seattle. In her interview, she describes the Return-to-Learn pilot Program that she and her team have created, which, thanks to a grant from the CDC, they will implement and study at 24 public high schools across Washington State.

Concussion Alliance interview with Dr. Eve Valera, research scientist at Massachusetts General Hospital and Associate Professor of Psychology in the Department of Psychiatry at Harvard Medical School. Dr. Valera studies Intimate Partner Violence (IPV) and domestic-violence-induced traumatic brain injuries (TBIs) in women.

Two new studies have come out with compelling evidence, further linking hormonal dysfunction with concussions.